AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gpnyl M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Kasnav Pharma

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Gpnyl M 1mg/500mg Tablet SR

Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a healthy diet, regular physical activity, and weight management as advised by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and potential blood tests to assess blood cell counts and liver function will be recommended by your doctor.

Primary Ingredients of Gpnyl M 1mg/500mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Gpnyl M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Gpnyl M 1mg/500mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume the Gpnyl M 1mg/500mg sustained-release tablet with food.

Common Side effects of Gpnyl M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Gpnyl M 1mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet; do not chew, crush, or fracture it. Administer Gpnyl M 1mg/500mg Extended-Release Tablet with a meal.

How Gpnyl M 1mg/500mg Tablet SR works:

Glimepiride/Metformin 1mg/500mg Extended-Release Tablets (Gpnyl M) combine two distinct antidiabetic agents to manage blood sugar levels. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, acts through a triple mechanism: reducing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Gpnyl M 1mg/500mg Tablet SR ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Gpnyl M 1mg/500mg tablet might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Gpnyl M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gpnyl M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Close monitoring of renal function is recommended during treatment. Consult a physician before use.

LiverLiverCAUTION

Patients with liver impairment should use Gpnyl M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin with a low dose. Gpnyl M 1mg/500mg Tablet SR is contraindicated in those with severe liver disease. Physician consultation is advised.

What if you forget to take Gpnyl M 1mg/500mg Tablet SR :

Should you forget a dose of Gpnyl M 1mg/500mg Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gpnyl M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gpnyl M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Gpnyl M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Gpnyl M 1mg/500mg Tablet SR and seek immediate medical attention.
Gpnyl M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gpnyl M 1mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Gpnyl M 1mg/500mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary difficulties, cognitive changes, and ataxia. To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Gpnyl M 1mg/500mg SR Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Gpnyl M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Gpnyl M 1mg/500mg Tablet ...
73
MRP 85
14% off